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Binding of f 3H]PK 11195, an isoquinoline carbox~ide derivative, was measured in microdissected tubule 
segments of rat nephron. High specific binding capacities (1.1-1.8 fmol.mm-‘) were found in the thick 
ascending limb of the Henle’s loop and in the collecting tubule, whereas specific binding could not be 
detected in the proximal tubule. In the medullary collecting tubule, the association and dissociation rate 
constants at 4°C were kr = 3.0 x lo6 M-‘.min-r and k-r = 0.021 min-‘; the ratio k-l/k1 = 7.0nM was 
in agreement with the estimated equilibrium dissociation constant (& = 2.4 nM). [3H]PK 11195 binding 
sites from medullary ascending limb and medullary coIlecting tubule revealed the following sequence of 
specificity: PK 11195 = Ro S-4864 % clonazepam, indicating that tubule binding sites might be the 
peripheral ~nzodiazepine receptors of the rat kidney. 
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1. INTRODUCTION 
High-affinity receptors for benzodi~epines have 
been found in the brain and several other tissues 
including the kidney [l-4]. The neuronal receptors 
have been distinguished from those present on glial 
elements and peripheral tissues on the basis of their 
respective recognition patterns for a series of 
benzodiazepine analogues. Thus, clonazepam, a 
potent anxiolytic drug, binds with high affinity to 
brain receptors and with low affinity to peripheral 
receptors. Conversely, Ro5-4864, a benzodiaze- 
pine devoid of anxiolytic activity, exhibits low 
affinity for central receptors and high affinity for 
peripheral receptors [l-4]. Furthermore, 1-(2- 
chlorophenyl)-N-methyl-N-(I-methylpropyl)-3-iso- 
quinoline carboxamide, or PK 11195, a product 
chemically unrelated to the benzodiazepines, was 
Abbrevjatjo~~~ PCT, proximal convohtted tubule; PR, 
pars recta; MAL, medullary thick ascending limb; CAL, 
cortical ascending limb; CCT, cortical collecting tubule; 
MCT, medullary collecting tubule 
at least potent as RoS-4864 for displacing [3H]Ro5- 
4864 in all organs tested [5,6]. 
The aim of this work was to determine the locali- 
zation of peripheral benzodiazepine receptors 
along the rat nephron by measuring binding of 
13H]PK 11195 in discrete nephron segments ob- 
tained by microdissection. The results indicate that 
significant binding to receptors of high affinity 
occurs in the glomeruli, the thick ascending limbs 
of the Henle’s loop and in the collecting tubules. 
2. MATERIALS AND METHODS 
2.1. Tubule microdissection 
Animals used were male Wistar rats (200-250g 
body wt) purchased from the Janvier Breeding 
Center (France). Tubule microdissection was per- 
formed as in [7]. The left kidney was perfused via 
the renal artery with 4ml of a cold modified 
Hank’s solution containing 0.25% collagenase 
(type I, Sigma), 0.1% bovine serum albumin and 
1 mM CaClz. Thin pyramids cut along the cortico- 
papillary axis were incubated in the same solution 
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at 35°C for 15-20min. After rinsing, the slices 
were microdissected by hand in ice-cold Hank’s 
solution under stereomicroscopic observation. 
Tubules were photographed for length determina- 
tion and kept at 4°C until assay. 
2.2. [3HJPK 11195 binding assay 
Tubules from the same nephron segment (aver- 
age total length, 1 .O-2.0 mm) were incubated for 
120 min at 4°C in a 2.5~1 droplet of medium con- 
taining 20 mM Tris-HCI (pH 7.4), 137 mM NaCI, 
5 mM KCl, 0.8 mM MgS04, 0.33 mM NazHPOd, 
0.44 mM KHzP04,l mM MgClz, 1 mM CaC12, and 
various amounts of [3H]PK 11195 (40 Ci/mmol, 
Amersham). Radioactivity bound to tubules was 
separated from free labelled ligand by rapid filtra- 
tion of samples through Whatman GF/C glass 
filters. Filters were washed 5 times with 5 ml cold 
20 mM Tris-HCl (pH 7.4), 1 mM MgC12. Radio- 
activity retained on the filter was counted for 
50 min by liquid scintillation spectrometry. Non- 
specific binding was measured in the presence of 
5/cM unlabelled PK 11195. Blanks incubated under 
identical conditions were run in each experiment. 
The apparent dissociation constants for unla- 
belled PK 11195 and benzodiazepines were deduced 
from the determination of the dose-dependent in- 
hibition of 5 nM [3H]PK 11195 binding. 
Control experiments indicated that: (i) keeping 
overnight tubules at 4°C did not alter specific and 
non-specific [ 3H] PK 11195 binding and (ii) assaays 
performed for 120min at 4°C or 20min at 30°C 
gave the same values for maximal binding capaci- 
ties, apparent dissociation constants and Hill 
coefficients. 
3. RESULTS AND DISCUSSION 
Fig.1 shows that total and non-specific binding 
of [3H]PK 11195 to MAL and MCT was propor- 
tional to tubular length throughout the entire 
range tested, and the same observation also ap- 
plied for CAL and CCT. On these grounds, results 
were expressed as fmol bound [3H] PK 11195 per 
mm of tubule. 
Specific binding of [3H]PK 11195 to MCT was a 
process saturable with time (fig.2). At 4°C and for 
7.7 nM ligand, about 60 min were needed to reach 
equilibrium, the half-time for binding being 
15 min. Addition of a large excess of unlabelled 
I 
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Fig.1. Effect of tubule length on total and non-specific 
[‘HI PK 11195 binding to medullary thick ascending limb 
(MAL) and medullary collecting tubule (MCT). Tubules 
were incubated with 20nM [3H]PK 11195 in the absence 
(total binding, M) or presence (non-specific binding, 
w) of 5pM unlabelled PK 11195. The equations of 
the linear egression li es drawn on the graph are the fol- 
lowing: MAL (0) y = 1.43x - 0.11 (f = 0.964, P c 0.01); 
MAL (0) y = 0.09x + 0.04 (r = 0.774, P.< 0.01). MCT 
(0) y = 1.20x + 0.12 (r = 0.987, P c 0.01); MCT (0) 
y = 0.23x - 0.09 (r = 0.888, P < 0.01). 
PK 11195 to pre-equilibrated tubules induced an 
almost dissociation of bound ligand. 
The dose dependencies of total and non-specific 
[3H]PK 11195 binding to MAL and MCT are illus- 
trated in fig.3. The non-specific binding increased 
linearly and was negligible for concentrations lower 
than 5 nM. In both segments, the specific compo- 
nent of binding saturated in a ligand concentration 
range lower than 2 orders of magnitude. The trans- 
formation of the dose-dependent specific binding 
curves in the Scatchard coordinates generates cur- 
vilinear plots and in the Hill coordinates gives 
straight lines whose slopes are n = 1.71 and 1.56 
for MAL and MCT, respectively. These data sug- 
gest the existence of a slight positive cooperativity 
in the interaction process between [3H]PK 11195 
and tubular binding sites. The apparent dissocia- 
tion constants calculated from the x intercepts of 
the Hill plots are Kd = 3.1 and 2.4 nM for MAL 
and MCT, respectively. For MCT, this Kd value is 
in the same range as that calculated from the dis- 
sociation and association rate constants 
(k-i/k, = 7.0nM, see legend to fig.1). 
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Fig.2. Kinetics of association and dissociation of 
[ ‘H]PK 11195 binding to medullary collecting tubules. 
MCT were incubated in the presence of 7.7nM 
[3H]PK 11195 and specific binding was measured as a 
function of incubation time at 4°C (left). Binding reversi- 
bility was induced by adding 5&M unlabelled PK 11195 
in the incubation medium of tubules preincubated for 
120 min with 7.7 nM [3H]PK 11195 and the remaining 
specific binding was measured as a function of time 
(right). Values are means *SE of 4-5 determinations. 
The kr and k-r association and dissociation rate 
constants were determined from the semilogarithmic 
plots shown in the lower part of the figure, assuming 
that the binding process corresponds to the reaction 
L+R++ LR, in which L, R and LR are free 
ligand, free ieceptor and the ligand-receptor complex, 
respectively. The association and dissociation time 
courses are expressed by eqsl and 2, respectively: 
log(~~eq/L~eq - LR) = (ktL + k-$ (1) 
log(LZ?/LReq) = --k-l t (2) 
in which LReq is the concentration of ligand-receptor 
complex at equilibrium. The equations of the linear 
regression lines drawn on the graph are the following: 
(left) y = 0.044~ - 0.056 (r = 0.999, P c 0.01); (right) 
y = -0.021x - 0.180 (r = 0.972. P < 0.01). Computation 
gives kr = 3.0 x lo6 M-‘.min-’ and k-r = 0.021 min-‘. 
The detected 13H]PK 11195 tubule binding sites 
exhibited a high degree of specificity (table 1). 
RoS-4864, a benzodiazepine almost devoid of an- 
xiolytic activity,~ was as effective as unlabelled 
PK 11195 in inhibiting [3H]PK 11195 binding, 
whereas clonazepam, a potent anxiolytic benzodia- 
zepine was found unable to interact with labelled 
binding sites. This ligand specificity is similar to 
that of the membrane-bound and solubilized ben- 
zodiazepine receptors from rat kidney f3-51. Thus, 
it seems likely that tubule binding sites detected 
using the labelled ligand PK 11195, a product 
chemically unrelated to the benzodiazepines, might 
represent he peripheral benzodiazepine receptors 
of the rat kidney. 
The distribution of [3H]PK 11195 binding sites 
along the rat nephron is shown in table 2. High 
specific binding capacities were found in the glo- 
meruli, MAL, CAL, CCT and MCT, whereas 
specific binding was not statistically different from 
zero in the PCT and PR. An effect of the collage- 
nase pretreatment on the binding characteristics of 
various nephron segments i  unlikely since this pro- 
cedure did not alter the number of insulin receptors 
[S], the response of adenylate cyclase to various 
hormones [9] and the activity of (Na+ + K+)- 
ATPase [lo, 111. The high non-specific binding 
observed in PCT might correspond to the presence 
of a tubular carrier of low affinity for PK 11195, 
but this hypothesis calls for additional investiga- 
tions. In addition, the distribution of specific 
[3H]PK 11195 binding sites along the nephron is in 
good agreement with autoradiographi~ studies 
which showed radiolabelled ligand mainly in the 
glomeruli and in the outer medulla of rat kidney 
(Benavides, personal communication). 
Previous studies, using membranes prepared 
from whole rat kidney, showed that the number 
of benzodiazepine receptors [3-51 was several- 
Table 1 
Apparent dissociation constants for binding of PK 11195 
and benzodiazepines to medullary thick ascending limb 
(MAL) and medullary collecting tubule (MCT) 
MAL MCT 
PK 11195 2.2 nM 5.0nM 
RoS-4864 4.9 nM 2.2 nM 
Clonazepam > 30pM > 30pM 
The apparent dissociation constants for the unlabelled 
compounds were calculated from Go values; i.e., concen- 
trations of drug leading to half-maximal inhibition of 
[‘HJPK 11195 specific binding 
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Fig.3. Dose dependency of total and non-specific binding of [3H]PK 11195. Segments of medullary thick ascending limb 
(MAL, left) or medullary collecting tubule (MCT, right) were incubated with increasing amounts of [3H]PK 11195 in 
the absence (total binding, M) or presence (non-specific binding, M) of 5pM unlabelled PK 11195. Values are 
means +SE of 3-5 determinations. Transformation of the specific component of the dose-dependent binding curves 
(- - -) in the Hill coordinates gives straight lines whose equations of linear regression are the following: 
MAL:y= 1.71x+ 14.55 (r=O.962, PcO.01); MCT:y= 1.56x+ 13.46 (r=0.921, P<O.Ol). t 
fold higher than that of the receptors to various 
hormones [12-141. Here too, the maximal 
[3H]PK 11195 specific binding capacity of the col- 
than the respective numbers of aldosterone and in- 
sulin receptors [8,15]. Such a large concentration 
of peripheral benzodiazepine binding sites re- 
letting tubule is about lOO- and 200-fold higher stricted to defined segments of the nephron raises 
Table 2 
[3H]PK 11195 binding along the rat nephron 
Glomerulus 
Total binding 
0.38 + 0.06 (7) 
Non-specific binding 
(fmol bound per glomerulus) 
0.12 f 0.07 (7) 
Specific binding 







(fmol bound per nm) 
1.12 + 0.55 (14) 0.63 f 0.33 (17) 0.49 + 0.44 NS 
0.35 f 0.23 (7) 0.11 f 0.09 (7) 0.24 + 0.17 NS 
1.26 + 0.24 (18) 0.14 * 0.06 (16) 1.12 + 0.18* 
1.86 f 0.33 (8) 0.10 + 0.09 (7) 1.76 f 0.25* 
1.25 + 0.41 (7) 0.05 f 0.06 (7) 1.20 * 0.30* 
1.24 f 0.15 (15) 0.13 * 0.08 (12) 1.11 * 0.13* 
Assays were performed at 20nM [3H]PK 11195. Results are means * SD of n determinations (n, in parentheses). 
Quadratic f SD values of specific binding were compared to zero using Student’s t-test (NS, not significant; *, P < 0.01) 
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the obvious question about their function and 
biologic significance which are unknown. How- 
ever, it has been shown that the number of renal 
benzodiazepine receptors was greater in rats of the 
Brattleboro strain with hereditary hypothalamic 
diabetes insipidus than that of normal rats of the 
same Long Evans hooded strain and that chronic 
treatment of Brattleboro with vasopressin returned 
this number of receptors to Long Evans control 
level [16]. In addition, the number of renal benzo- 
diazepine receptors seems to be altered in hyper- 
tensive rats of the deoxycorticosterone/salt model 
[17,18]. It is worth noting that the distribution of 
benzodiazepine binding sites along the nephron 
covers the target cells of vasopressin on the one 
hand and those of aldosterone on the other. Vaso- 
pressin is known to induce contraction of glomeru- 
lar mesangial cells through cyclic AMP-indepen- 
dent mechanisms [19] and to promote adenylate 
cyclase activation in the thick ascending limb of 
the Henle’s loop and in the cortical and medullary 
portions of the collecting tubule [7], whereas aldo- 
sterone receptors are localized in the branched, 
cortical and medullary portions of the collecting 
tubule [15]. These observations might indicate a 
possible relationship between benzodiazepine re- 
ceptors and vasopressin and mineralocorticoid 
actions in the kidney. 
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